Natural Killer Cells Derived From Human Pluripotent Stem Cells Provide a Novel Method to Treat HIV-1 Infection.
Ni Z, Knorr D, Clouser C, Southern P, Mansky L, Park I, Kaufman D. Natural Killer Cells Derived From Human Pluripotent Stem Cells Provide a Novel Method to Treat HIV-1 Infection. Blood 2009, 114: 280. DOI: 10.1182/blood.v114.22.280.280.Peer-Reviewed Original ResearchHIV-1-infected targetsNatural killer cellsHIV-1 infectionHuman CD4 T cellsUmbilical cord blood progenitor cellsNK cell populationNK cellsPrimary human CD4 T cellsCD4 T cellsBlood progenitor cellsHIV-1 replicationCord blood progenitor cellsKiller cellsT cellsUninfected targetsProgenitor cellsHIV-1-infected cell linesAcute HIV-1 infectionHIV-1-infected cellsAntibody-dependent cellular cytotoxicityHIV-1 NL4-3Human umbilical cord blood progenitor cellsTumor cellsExpression of CD107aIPSC-NK cells